We continued to execute our strategy in relation to our pipeline delivery, portfolio focus, geographic expansion and acquisition.
Welcome to the 2019 Annual Report in which you will read about another year of strategic and financial progress across the business.
Summarising the year, I can report that the business has delivered a strong performance as we continued to execute our strategy in relation to our pipeline delivery, portfolio focus, geographic expansion and acquisition.
The Board is confident in the long term prospects of the global animal health market. We see Companion Animal Products (CAP) continuing to be the main driver of growth, although we are encouraged by the opportunity that Equine and Food producing Animal Products (FAP) offer. We have strengthened our product development portfolio to which we expect to add further products to and global registrations over the coming years.
As the Group continues to go from strength to strength, I take this opportunity on behalf of all stakeholders, to sincerely thank all our people (who now total 1,753 working across 25 countries) for their ongoing commitment and dedication which continues to underpin the success of Dechra.
More detail can be read as part of the Strategic Report that follows my letter. I hope that you will find this document interesting and informative and, as always, we welcome feedback or questions from shareholders.
We look forward to keeping you and the market updated on our positive progress over the coming year.
Read about our Corporate Governance